·       Largest real-world, blinded, multi-site validation of AI molecular profiling from routine diagnostic images ·       Software identifies clinically actionable cancer biomarkers in minutes rather than weeks ·       Study led by University of Leeds and Leeds Teaching Hospitals NHS Trust, with validation across three independent healthcare institutions ·       Findings published in npj Digital Medicine, support faster, more accessible precision medicine for colorectal cancer patients...

Cambridge, UK, 3 November 2025  – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm that various team members will be attending and presenting at a number of conferences as detailed below. Panakeia’s AI-driven software provides comprehensive multi-omic information (DNA, RNA, protein, metabolite changes) directly from routinely used images of tissues and cells in minutes instead of days or weeks, without the need for wet-lab tests. The...

Cambridge, UK, 5 September 2025  – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to...